Valuation: Evotec SE

Market Cap 519M 584M 484M 442M 833M 56.16B 840M 5.86B 2.27B 28.71B 2.19B 2.15B 92.14B P/E 2026 *
-2.29x
P/E 2027 * -6.79x
Enterprise Value 662M 745M 618M 563M 1.06B 71.61B 1.07B 7.48B 2.9B 36.61B 2.8B 2.74B 117B EV / Sales 2026 *
1.1x
EV / Sales 2027 * 0.94x
Free-Float
89.91%
Yield 2026 *
-
Yield 2027 * -
1 day-3.57%
1 week+3.91%
Current month-5.81%
1 month-11.68%
3 months-43.25%
6 months-35.15%
Current year-46.42%
1 week 2.79
Extreme 2.788
3.14
1 month 2.71
Extreme 2.71
3.27
Current year 2.71
Extreme 2.71
6.73
1 year 2.71
Extreme 2.71
7.3
3 years 2.71
Extreme 2.71
21.69
5 years 2.71
Extreme 2.71
45.47
10 years 2.71
Extreme 2.71
45.83
Manager TitleAgeSince
Chief Executive Officer 55 01/07/2024
Director of Finance/CFO - 01/05/2026
Chief Operating Officer - 01/05/2026
Director TitleAgeSince
Director/Board Member 58 19/06/2019
Director/Board Member 64 01/06/2021
Director/Board Member 59 10/06/2024
Date Insider Type Main position Quantity % Market Cap. Importance
20/5/26 Exercice

Chief Technology Officer

12,462 0.0070%
4/5/26 Buy 15,510 0.0087%
4/5/26 Buy

Head of Human Resources

15,228 0.0086%
Change 5-day change 1-year change 3-year change Capi.($)
-3.57%+3.91%-55.84%-83.72% 584M
+4.16%+3.04%+49.37%+94.17% 74.16B
-3.11%-3.53%+21.92%+74.60% 57.39B
+0.89%-0.63%+4.28%+34.51% 47.64B
+0.36%+0.81%+352.17%+689.61% 44.29B
-0.96%-4.50%+26.36%+33.18% 42.5B
-0.20%-0.77%+3.74%+100.60% 40.71B
-0.54%+2.93%+9.31%+50.41% 30.97B
-2.68%+2.92%+29.63%+19.50% 28.53B
+0.05%-1.64%-7.28%-14.06% 24.34B
Average -0.56%-0.14%+43.37%+99.88% 39.11B
Weighted average by Cap. +0.12%-0.83%+58.59%+129.59%

Financials

2026 *2027 *
Net sales 601M 676M 561M 511M 964M 65.01B 973M 6.79B 2.63B 33.24B 2.54B 2.48B 107B 724M 815M 676M 616M 1.16B 78.35B 1.17B 8.18B 3.17B 40.05B 3.06B 2.99B 129B
Net income -222M -250M -207M -189M -356M -24.02B -359M -2.51B -972M -12.28B -938M -918M -39.41B -48.25M -54.31M -45.03M -41.05M -77.41M -5.22B -78.13M -545M -211M -2.67B -204M -199M -8.57B
Net Debt 143M 161M 133M 122M 229M 15.46B 231M 1.61B 625M 7.9B 604M 591M 25.36B 162M 183M 151M 138M 260M 17.55B 263M 1.83B 710M 8.97B 685M 670M 28.79B
Logo Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Employees
4,461
Date Price Change Volume
02/10/26 EUR 2.920 -3.57% 662,385
01/10/26 EUR 3.028 -2.32% 1,100,114
30/09/26 EUR 3.100 +5.08% 987,770
29/09/26 EUR 2.950 +3.15% 1,043,914
28/09/26 EUR 2.860 +1.78% 1,544,301
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
2.920EUR
Average target price
4.586EUR
Spread / Average Target
+57.04%

Quarterly revenue - Rate of surprise